[MYGN] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
04-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 7.59%
YoY- 51.80%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 196,500 177,500 186,500 190,500 193,300 183,500 189,900 2.29%
PBT 12,100 4,000 37,300 43,100 45,000 43,500 35,500 -51.04%
Tax 6,200 5,200 13,900 10,500 14,700 16,900 16,800 -48.39%
NP 5,900 -1,200 23,400 32,600 30,300 26,600 18,700 -53.49%
Tax Rate -51.24% -130.00% -37.27% -24.36% -32.67% -38.85% -47.32% -
Total Cost 190,600 178,700 163,100 157,900 163,000 156,900 171,200 7.38%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 3.00 -0.68 12.55 17.11 15.68 14.50 9.85 -54.56%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS 0.09 -0.02 0.33 0.49 0.43 0.39 0.27 -51.76%
EPS Diluted 0.09 -0.02 0.32 0.47 0.41 0.37 0.26 -50.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.